-
Recent Posts
- Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Spikes with Promise of Tasimelteon
- Is Enviro-Serv, Inc. (PINKSHEETS: EVSV) Any Closer to Generating Revenues?
- Eagle Bulk Shipping, Inc. (NASDAQ: EGLE) Spikes on Earnings but is there More to the Numbers?
- Is Gold in the Future for FBC Holding, Inc. (OTCQB: FBCD)?
- Will it be Clear Sailing for Alas International Holdings, Inc. (PINKSHEETS: VDSC)?
Categories
OTC Equity Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tags
aapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods cloud computing copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare stocks investors ipad iphone mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical pinksheets Pink Sheets s silver sprint stocks tradingSite
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Blog Archives
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Spikes with Promise of Tasimelteon
While it has been more than a week since Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) released their first quarter financial and operational results it was today that the biopharmaceutical company focused on the development and commercialization of products for the treatment … Continue reading
Posted in Articles, NASDAQ
Tagged biopharmaceutical, fda, investors, sleep disorder, tasimelteon, vanda pharmaceuticals, vnda
Leave a comment
Is Enviro-Serv, Inc. (PINKSHEETS: EVSV) Any Closer to Generating Revenues?
Over the past month Enviro-Serv, Inc. (PINKSHEETS: EVSV) has seen their share price take a staggering hit, falling from a high of 0.0560 on April 9, 2013 down to a 52-week low of 0.0023 today, and with no real operations … Continue reading
Posted in Uncategorized
Tagged air conditioning, enviro-serv, evsv, investors, landscaping, maintenance, pest control, trina
Leave a comment
Eagle Bulk Shipping, Inc. (NASDAQ: EGLE) Spikes on Earnings but is there More to the Numbers?
The response to yesterday’s release of first quarter results for Eagle Bulk Shipping, Inc. (NASDAQ: EGLE) has been overwhelmingly positive as the company, which is a leading global owner of Supramax dry bulk vessels that range in size from 50,000 … Continue reading
Posted in Articles, NASDAQ
Tagged bulk cargoes, dry bulk market, dry bulk vessels, eagle bulk, egle, investors, klc, shipping
Leave a comment
Is Gold in the Future for FBC Holding, Inc. (OTCQB: FBCD)?
Apparently FBC Holding, Inc. (OTCQB: FBCD) has learned that the best way to attract investor attention and push their share price north is abandon a failed business plan and start anew; developing operations related to gold mining or gold mining … Continue reading
Posted in Uncategorized
Tagged dgri, fbc holding, fbcd, gold, gold mining, gold mining services, gold resources, investors
Leave a comment
Will it be Clear Sailing for Alas International Holdings, Inc. (PINKSHEETS: VDSC)?
Without question Alas International Holdings, Inc. (PINKSHEETS: VDSC), aka PV Enterprises International Inc., has been making waves of late with their continued updates regarding their progress in establishing cruise and ferry operations worldwide. The flood of press releases has aided … Continue reading
Posted in Uncategorized
Tagged alas international, captiva, cruise, ferry, investors, pv enterprises, revenue, ship lodging, vdsc
Leave a comment
Rockwell Medical, Inc. (NASDAQ: RMTI) to Use Public Offering to Complete Late-Stage Clinical Trials
Almost one year ago shares of Rockwell Medical, Inc. (NASDAQ: RMTI) were trading as high as 10.70 but those days must seem like a distant memory for the fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease … Continue reading
Posted in Articles, NASDAQ
Tagged biopharmaceutical, end-stage renal disease, investors, kidney disease, rmti, rockwell medical
Leave a comment
Is Trulan Resources, Inc. (PINKSHEETS: TRLR) In Over Their Heads with Gold Property in Chile?
When a company like Trulan Resources, Inc. (PINKSHEETS: TRLR) outlines their mission as “the exploration and development of mining properties whose economic potential is considered to be extensive, while requiring minimal infrastructure and operational costs, that can be advanced in … Continue reading
Posted in Uncategorized
Tagged chile, gold, industrial minerals, investors, mining properties, platinum, trlr, trulan resources
Leave a comment
Has Terra Tech Corp. (OTCBB: TRTC) Figured Out How to Control Costs?
While Terra Tech Corp. (OTCBB: TRTC) has certainly been busy distributing press releases over the past few weeks their efforts have done little to boost the company’s share price, in fact the “leader in sustainable agricultural products” actually slid to … Continue reading
Posted in Uncategorized
Tagged agricultural products, hydroponic greenhouse, investors, specialty plants, terra tech, trtc
Leave a comment
Alimera Sciences, Inc. (NASDAQ: ALIM) Building Off ILUVIEN’s Success
Alimera Sciences, Inc. (NASDAQ: ALIM) surged to a 52-week high of 3.98 on Monday, this after closing Friday’s trading session at 3.11, while volume in the biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals … Continue reading
Posted in Articles, NASDAQ
Tagged alim, alimera sciences, biopharmaceutical, diabetes, diabetic, dme, fda, iluvien, investors, pdufa
Leave a comment
Theragenics Corp. (NYSE: TGX) Weighing Takeover Offer from Juniper Investment Co.
Shares of Theragenics Corp. (NYSE: TGX) climbed to a 52-week high of 2.15 today after the medical device company serving the surgical products and prostate cancer treatment markets issued a press release announcing that they had received a takeover offer … Continue reading
Posted in Articles, NYSE
Tagged cancer, investors, juniper, medical device, prostate cancer, surgical products, tgx, theragenics
Leave a comment


